Platform - IsoPlexis Solutions
After the CAR-T cells are produced, there are still challenges in determining effectiveness. The single-cell functional proteomics platform from IsoPlexis, however, helps a researcher assess the true function of their engineered cell products. Specifically, it reveals polyfunctional T cells, which produce two or more cytokines simultaneously. The IsoPlexis technology captures the highly multiplexed cytokine signatures from each cell, revealing the unique power of the individual supercell.
KCAS is ready to put the IsoPlexis to work for your project
KCAS can identify the most potent and effective cells within a CAR-T cell product. Our customers can use this data to compare the results of different methods of preparing therapeutic T cells. Then, a method can be optimized to produce CAR-T cells that exhibit the desired properties.
KCAS IsoPlexis Services
Methods transferred into a new laboratory need to be re-established for regulatory compliance….
At KCAS, methods are developed with a fit-for-purpose design in mind, based on our Client’s ne…
A fit-for-purpose approach is used by KCAS in method qualifications. Each method is designed t…
KCAS has extensive experience in validating methods in a wide range of bioanalytical platforms…
Multi-plex analysis of biomarkers is a powerful tool for screening of many analytes in a small…
Regulated clinical bioanalysis is a key focus at KCAS, supporting both human and animal health…
The discovery phase in drug development requires rapid and reliable data in making key decisio…
PD Analysis is the assistance with design, regulatory requirements and final data interpretati…
Tissue bioanalysis is an essential area in understanding the extent of drug distribution, meta…